Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1994 Apr;31(4):317–320. doi: 10.1136/jmg.31.4.317

Complementation studies in Niemann-Pick disease type C indicate the existence of a second group.

S J Steinberg 1, C P Ward 1, A H Fensom 1
PMCID: PMC1049805  PMID: 8071958

Abstract

Niemann-Pick disease type C is a clinically heterogeneous storage disorder with an unknown primary metabolic defect. We have undertaken somatic cell hybridisation experiments using skin fibroblast strains from 12 patients representing a wide clinical spectrum. Preliminary experiments using filipin staining of free cholesterol as a marker for complementation indicated the existence of one major group (group alpha) and one minor group (group beta) represented by one mutant strain. Subsequent experiments in which sphingomyelinase activity was measured as a marker for complementation using five mutant strains showing activity consistently < 40% control levels confirmed the existence of the second group.

Full text

PDF
317

Images in this article

319Image
on p.319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besley G. T., Hoogeboom A. J., Hoogeveen A., Kleijer W. J., Galjaard H. Somatic cell hybridisation studies showing different gene mutations in Niemann-Pick variants. Hum Genet. 1980;54(3):409–412. doi: 10.1007/BF00291589. [DOI] [PubMed] [Google Scholar]
  2. Carstea E. D., Polymeropoulos M. H., Parker C. C., Detera-Wadleigh S. D., O'Neill R. R., Patterson M. C., Goldin E., Xiao H., Straub R. E., Vanier M. T. Linkage of Niemann-Pick disease type C to human chromosome 18. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2002–2004. doi: 10.1073/pnas.90.5.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fensom A. H., Benson P. F., Grant A. R., Jacobs L. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes. J Inherit Metab Dis. 1980;2(1):9–12. doi: 10.1007/BF01805555. [DOI] [PubMed] [Google Scholar]
  4. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  5. Levran O., Desnick R. J., Schuchman E. H. Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3748–3752. doi: 10.1073/pnas.88.9.3748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Pentchev P. G., Comly M. E., Kruth H. S., Vanier M. T., Wenger D. A., Patel S., Brady R. O. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8247–8251. doi: 10.1073/pnas.82.23.8247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Quintern L. E., Schuchman E. H., Levran O., Suchi M., Ferlinz K., Reinke H., Sandhoff K., Desnick R. J. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 1989 Sep;8(9):2469–2473. doi: 10.1002/j.1460-2075.1989.tb08382.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Roscher A. A., Hoefler S., Hoefler G., Paschke E., Paltauf F., Moser A., Moser H. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Pediatr Res. 1989 Jul;26(1):67–72. doi: 10.1203/00006450-198907000-00019. [DOI] [PubMed] [Google Scholar]
  9. Thomas G. H., Tuck-Muller C. M., Miller C. S., Reynolds L. W. Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media. J Inherit Metab Dis. 1989;12(2):139–151. doi: 10.1007/BF01800716. [DOI] [PubMed] [Google Scholar]
  10. Vanier M. T., Rodriguez-Lafrasse C., Rousson R., Duthel S., Harzer K., Pentchev P. G., Revol A., Louisot P. Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci. 1991;13(4-5):307–314. doi: 10.1159/000112178. [DOI] [PubMed] [Google Scholar]
  11. Vanier M. T., Rodriguez-Lafrasse C., Rousson R., Gazzah N., Juge M. C., Pentchev P. G., Revol A., Louisot P. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta. 1991 Jun 5;1096(4):328–337. doi: 10.1016/0925-4439(91)90069-l. [DOI] [PubMed] [Google Scholar]
  12. Vanier M. T., Wenger D. A., Comly M. E., Rousson R., Brady R. O., Pentchev P. G. Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet. 1988 May;33(5):331–348. doi: 10.1111/j.1399-0004.1988.tb03460.x. [DOI] [PubMed] [Google Scholar]
  13. Viana M. B., Giugliani R., Leite V. H., Barth M. L., Lekhwani C., Slade C. M., Fensom A. Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis. J Med Genet. 1990 Aug;27(8):499–504. doi: 10.1136/jmg.27.8.499. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES